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 Abstract: 
Chronic stress is closely linked to clinical depression, which could be assessed by a chronic 
unpredictable mild stress (CUMS) animal model. We present here a GC/MS-based metabolic 
profiling approach to investigate neurochemical changes in the cerebral cortex, hippocampus, 
thalamus, and remaining brain tissues. Multi-criteria assessment for multivariate statistics could 
identify differential metabolites between the CUMS-model rats versus the healthy controls. This 
study demonstrates that the significantly perturbed metabolites mainly involving amino acids 
play an indispensable role in regulating neural activity in the brain. Therefore, results obtained 
from such metabolic profiling strategy potentially provide a unique perspective on molecular 
mechanisms of chronic stress. 
Keywords: Chronic unpredictable mild stress; Metabolic profiling; GC/MS; Multi-criteria 
assessment; Multivariate statistics; Amino acid 
Abbreviations: NMR, nuclear magnetic resonance; MS, mass spectrometry; GC/MS, gas 
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partial least squares project to latent structures-discriminant analysis; MCA, multi-criteria 
assessment; VIP, variable importance in the projection; CUMS, chronic unpredictable mild 
stress; SNS, sympathetic nervous system; CNS, central nervous systems; HPA, hypothalamic–
pituitary–adrenocortical; ECF, ethyl chloroformate; CIJFjk, jack-knifed confidence interval; 
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Article: 
1. Introduction 
Depression is a serious public mental but treatable problem, affecting about 12% of women and 
7% of men annually in USA [1]. It interferes often with normal feelings and behavior in people’s 
daily life, and causes severe psychological pain for the patients and their families. Current 
treatments for clinical depression commonly involve psychotherapy and antidepressant 
medications. The most popular types of these antidepressant drugs are selective serotonin 
reuptake inhibitors (SSRIs), e.g., fluoxetine, citalopram, sertraline and several others [2].  
 
Chronic unpredictable mild stress (CUMS), a well-validated animal model, has been used widely 
for studying clinical depression as well as evaluating antidepressant effects of diverse drugs [3] 
and [4]. Much of the work has been done successfully in individual gene expression, protein 
structure and function, as well as biochemical studies on sympathetic nervous system (SNS), 
hypothalamic–pituitary–adrenocortical (HPA)-axis, noradrenergic and immunological systems, 
etc. [5], [6], [7], [8], [9] and [10]. Recently, the emerging metabonomics or metabolomics [11] 
and [12] has gradually studied the intricate relationship between acute and/or chronic stress and 
certain crucial endogenous metabolites [13], [14], [15], [16] and [17]. Such metabolic profiling 
technology has been increasingly used as a versatile tool for the discovery of molecular 
biomarkers in many areas such as monitoring the chemical-induced toxicity in organs, 
diagnosing or prognosing clinical diseases, exploring the potential mechanism of diverse 
diseases, and assessing therapeutic effects of drugs [18], [19], [20] and [21]. Relying on the 
global metabolite changes in a given biological species, metabol/nomics requires little or no prior 
knowledge on a certain disease. Thus, it potentially provides not only a means of verifying the 
fragmentary findings from a great deal of individual previous research, but also a promising 
opportunity to generate novel hypothesis for addressing the molecular mechanisms of diseases, 
ultimately towards a comprehensive understanding of physiopathological outcomes of an 
organism in response to xenobiotic stimuli and/ or genetic modification.  
 
Biofuilds such as urine and plasma have been heavily used in metabol/nomic studies because 
they are minimally invasive to the animals or human and primarily reveal an overall metabolic 
state of the given organism [22]. By comparison, the tissue samples can offer a unique 
perspective on localized metabolic information. As the brain is a highly complex system 
encompassing a broad array of mutually interacting metabolites with varied chemical properties 
and specific biological functions, metabolic profiling of brain tissue samples will yield beneficial 
knowledge most related to neural activity of central nervous systems (CNS) [23], [24] and [25]. 
Yet no such study has been fully initiated to monitor neurochemical changes in a CUMS model. 
 
Recent metabolic profiling technology has successfully applied high-throughput analytical tools 
(e.g., NMR, nuclear magnetic resonance; MS, mass spectrometry) to analyze various biological 
samples and utilized multivariate statistics (e.g., PCA, principal component analysis; PLS, partial 
least squares projection to latent structures) to extract meaningful biological information from 
the resultant complex and huge data sets [26 and [27]. Variable selection is an important step in 
multivariate analysis that can apparently enhance our understanding and interpretability of 
multivariate models and commonly referred to VIP statistics, loading weights, and correlation 
coefficients [28], [29] and [30]. However, the practical use of these methods relies mostly on the 
experimental designs and purposes (e.g., animal or human studies, biomarker identification or 
pathway analysis), the size of samples, and preference of researchers as well [31] and [32]. A 
strict approach for selecting significant and reliable variables should likely be a combination of 
multiple criteria. For instance, the newly proposed S-plot combines both covariance and 
correlation deriving from multivariate modeling [31]. But the exact criterion for each method in 
variable selection is hitherto not addressed thoroughly. 
 
The primary goal of this work is to characterize neurochemical abnormalities in four discrete 
brain regions including cerebral cortex, hippocampus, thalamus, and the remaining regions from 
a rat model of CUMS. We applied a gas chromatography/mass spectrometry (GC/MS) technique 
to profile the brain tissue samples, and multi-criteria assessment (MCA) for multivariate 
statistics to select reliable variables accountable for class discrimination of metabolic profiles. 
The differential metabolites were verified partially by qualitative and quantitative analyses 
simultaneously. This work will not only provide a constructive protocol in choosing the most 
reliable and significant metabolites associated with a certain pathophysiological state when using 
metabolic profiling technology, but also expand our understanding of molecular mechanisms for 
diverse diseases. 
 
2. Materials and methods 
The schematic flowchart of the metabolic profiling strategy used in this study is illustrated in the 
Fig. 1. 
 
 
 
Fig. 1. Schematic flowchart of the metabolic profiling strategy used in this study. The 
homogenized tissue samples were extracted using ultrapure water and derivatized with ethyl 
chloroformate (ECF) (Step 1). The resultant derivatives were subsequently analyzed by a 
hyphenated technique – gas chromatography/mass spectrometry (GC/MS) (Step 2). Multivariate 
statistics was applied to extract meaningful information in the complex GC/MS spectral data 
(Step 3). Compounds with significant contribution to the variation of metabolic profiles between 
the CUMS-induced rats and healthy controls were identified in discrete brain regions using 
GC/MS spectral libraries including Wiley, NIST, NBS, etc., and further verified by reference 
compounds available (Step 4). Quantitative analysis of these verified metabolites was finally 
conducted by means of conventional calibration curves in order to accurately determine the 
concentrations of these metabolites in each brain region (Step 5). 
 
2.1. Animal handling, sampling and sucrose preference test 
The study was approved by national legislations of China and local guidelines. A total of twelve 
eight-week-old male Sprague–Dawley (SD) rats (n = 6 per group) was employed in this study 
and the animal experiment is described in the Supporting Materials. 
 
2.2. Sample preparation, GC/MS assay, and data acquisition and pretreatment 
The section was conducted as our previously described procedures [33] and is provided in the 
Supporting Materials. 
 
2.3. Multivariate and univariate statistics 
Multivariate statistics, including unsupervised PCA and supervised orthogonal partial least 
squares project to latent structures-discriminant analysis (OPLS-DA), was performed by 
SIMCA-P 11.0 software (Umetrics, Umeå, Sweden) [34] and [35]. The data set was mean-
centered and pareto-scaled in a columnwise manner for all the multivariate modeling [36]. Mean 
centering calculates the average spectrum of the data set and subtracts that average from each 
spectrum, aiming to focus on the fluctuating part of data instead of the original value. Pareto 
scaling weighs each variable by the square root of its standard deviation, which amplifies the 
contribution of lower concentration metabolites but not to such an extent where noise produces a 
large contribution. PCA technique was initially used to reduce the high dimensional data sets 
into a two- or three-dimensional scores map without losing profound information. The resulting 
PCA scores map was used for investigating natural interrelation including possible groupings, 
clustering, and outliers among observations. 
 
Furthermore, a more sophisticated OPLS-DA model was achieved through removing the 
variation in X matrix unrelated to Y matrix so that the specific discriminant information between 
classes can be interpreted using one predictive component alone [34] and [37]. Great efforts have 
been made to test the reliability of multivariate models [38] and [39], hence the 6-round cross-
validation in SMICA-P software was herein applied to validate the OPLS-DA model against 
over-fitting by precluding 1/6th of all the samples in each round. The cross-validated OPLS-DA 
scores map depicts the between-class separation (tp) and predictive ability (Q
2
Y) simultaneously 
[32]. Each individual in this map is represented by two spatial dots: one for model score value 
(tp) and the other for cross-validated score value (tcv). A smaller difference between the two score 
values suggests a better predictive accuracy (Q
2
Y). 
 
Additionally, unpaired student’s t-test implemented in Microsoft Office Excel 2007 (Microsoft 
(China) Co., Ltd. Beijing, China) was used to determine if the discriminant score values or the 
concentrations of the differential metabolites obtained from OPLS-DA modeling are statistically 
significant between classes at a univariate analysis level. The threshold of P value was set at 0.05 
throughout the study. 
 
2.4. Variable selection in OPLS-DA model 
The main purpose and procedure of variable selection is illustrated in the Fig. 2. Variable 
importance in the projection (VIP) ranks the overall contribution of each variable to the OPLS-
DA model, and those variables with VIP > 1.0 are considered statistically significant in this 
model. Herein, VIP statistics was initially applied to obtain the significant variables that could be 
used for metabolic pathway analysis [30]. Furthermore, MCA was used for choosing the most 
significant and reliable variables using a combination of VIP statistics, S-plot, and jack-knifed 
based confidence interval. S-plot combines the contribution/covariance (Cov(t,X)) and 
reliability/correlation (Corr(t,X)) from OPLS-DA model and helps to identify differential 
metabolites between classes [32]. Both of these two parameters have a theoretical minimum of 
−1 and maximum of 1. With a significance level of 0.05, a correlation coefficient (Corr(t,X)) of 
±0.58 was adopted as a cutoff value to select the variables that are most correlated with the 
OPLS-DA discriminant scores (predictive component). The correlation coefficients were 
calculated using Pearson linear correlation coefficients incorporated in MATLAB R2007a (The 
MathWorks, Inc., Natick, MA, USA. Details are available in the Supplementary Materials). The 
loading plot with CIJFjk displayed the uncertainty of each variable and the smaller span of 
confidence interval renders more creditability on the selected variable. In this study, those 
variables with CIJFjk across zero were excluded. Therefore, we merely chose those variables 
meeting the threefold criteria (i.e., VIP > 1, |Corr(t,X)| > 0.58, and the span of CIJFjk excluding 
zero) as the most significant and reliable variables, which could serve as candidate biomarkers 
for CUMS. 
 
 
Fig. 2. General purpose and procedure of variable selection. VIP statistics (VIP > 1.0) was 
initially opted to select the significant variables for biological pathway analysis while multi-
criteria assessment (MCA) was used for choosing the most significant and reliable variables 
(candidate biomarkers) by using a combination of VIP statistics, S-plot, and jack-knifed based 
confidence interval. 
 
2.5. Qualitative and quantitative analyses [40] 
Compound identification was processed by comparison of the ion fragments with those present 
directly in the GC/MS spectral databases including NIST, Wiley, and NBS, ultimately verified 
by reference compounds available. Additionally, the concentration of each verified metabolite 
was quantified via the corresponding calibration curve and was expressed as the relative 
percentage change. More details are provided in the Supporting Materials. 
 
3. Results 
3.1. Sucrose preference test and body weight gain 
The CUMS-treated rats consumed significantly less sucrose solution as compared to the healthy 
controls (66 ± 8% versus 96 ± 4%, P < 0.01, unpaired t-test), indicating depressive-like 
behavioral state (e.g., impairment of hedonic reactivity) in the stressed rats. Meanwhile, the 
CUMS-treated rats suffered significantly slower body weight gain than the healthy ones 
(45.8 ± 8.7 g versus 78.2 ± 4.0 g, P < 0.05). Details are available in the Supplementary Materials. 
All these findings confirmed the stress-related effects on the rat. 
 
3.2. GC/MS spectra of brain tissue samples 
Typical GC/MS total ion current (TIC) chromatograms of each part of brain tissue samples from 
the CUMS-treated rats (Supporting Fig. 1a–d) and the healthy rats (Supporting Fig. 1e–h) are 
illustrated. Visual inspection of these spectra revealed obvious difference either among discrete 
brain regions or between the CUMS-treated group versus the healthy control for each brain 
region, but the complexity of GC/MS spectra hampered further comparison between classes. 
Thus, we used our custom GC/MS analytical protocol in conjunction with peak deconvolution 
procedure [29], and obtained a three-dimensional matrix consisting of 48 samples, 161 peak 
indices (RT-M/Z pairs) presumably representing individual metabolites throughout all the tissue 
samples, and 161 peak intensity. The resulting data set was subsequently analyzed to extract 
useful information by multivariate statistics including PCA and OPLS-DA. 
 
3.3. Multivariate statistics 
A five-component PCA model was initially obtained from the GC/MS data set deriving from all 
the tissue samples (Table 1, Supporting Fig. 2a and b). The inherent metabolic difference among 
brain regions and in relation to stress factors can be reflected by a 2D-PCA scores plot (PC1 
versus PC3, Fig. 3). In this map, metabolic profiles of cerebral cortex and thalamus can be 
clearly separated from those of hippocampus and the remaining brain regions by the PC1 either 
in the CUMS-treated rats or in the healthy controls, while the stress-related metabolic variation 
was also readily noticed in the PC3. These findings mostly suggested that metabolic variations 
depicted by the PCA scores map were correlated with brain tissue regions and stress state as 
well. To gain more insights into stress-related metabolic variations in each brain compartment, 
the initial data set was divided into four subsets according to topographical region. The model 
quality was summarized in the Table 1. 
 
Table 1.  
Summary of the parameters for assessing modeling quality 
 
PCA model  
 
OPLS-DA model  
 
 
No
c
 R
2
Xcum
a
 No
c
 R
2
Xcum
a
 R
2
Ycum
a
 Q
2
Ycum
a
 
Cerebral cortex 3 0.65 1P + 1O
b
 0.40 0.96 0.71 
Hippocampus 3 0.76 1P + 1O 0.64 0.97 0.85 
Thalamus 3 0.75 1P + 1O 0.45 0.98 0.78 
Remaining regions 3 0.64 1P + 1O 0.45 0.91 0.60 
All tissue samples 5 0.67 
    
a
 R
2
Xcum and R
2
Ycum are the cumulative modeled variation in X and Y matrix, respectively, and 
Q
2
Ycum is the cumulative predicted variation in Y matrix. The values of these parameters close to 
1.0 indicate a robust mathematical model with a reliable predictive accuracy. 
b
 1P + 1O, one predictive component and one orthogonal Component for establishing the OPLS-
DA model. 
c
 No, the number of components.  
 
 
Fig. 3. (a) PCA scores map of GC/MS data derived from brain tissue samples in the CUMS-
treated group and the healthy control. C, cerebral cortex; H, hippocampus; T, thalamus; R, the 
remaining brain regions; N, the healthy control group; and M, the CUMS-treated group. Each dot 
denotes an individual rat. (b) Typical GC/MS total ion current (TIC) chromatogram of cerebral 
cortex from a healthy rat. The keys are provided in the Table 2. 
 
3.4. Cerebral cortex 
A 3D-PCA scores map showed that obvious separation of metabolic profiles between the 
CUMS-treated group and the healthy control occurred in the PC1 (Fig. 4a). The inter-class 
variation as indicated by the PCA map was also verified by the complete and significant 
separation (P < 0.01) in a cross-validated OPLS-DA score map (Fig. 4b). Additionally, the 
higher overlap between cross-validated scores (t[1]cv, i; i = 1–6) and the model scores (t[1]p) for 
most of cerebral cortex samples suggested the stability and reliability of the OPLS-DA model. 
 
 
Fig. 4. (a) 3D-PCA scores map and (b) 1D cross-validated OPLS-DA score map of GC/MS data 
deriving from cerebral cortex samples obtained from the CUMS-treated group versus the healthy 
control group (n = 6 per group). The modeled score value (t[1]p), the 6th round cross-validated 
score value (t[1]cv,6), and orthogonal score value (t[2]o) for each individual are illustrated for 
each observation. 
 
To identify which variables are accountable for such significant separation, VIP statistics was 
firstly used to pre-select variables (Fig. 5a). According to the criterion for VIP statistics 
(VIP > 1), a total of 28 variables were obtained for their most contribution in discriminating 
metabolic profiles between the two classes. Subsequently, relying on the MCA strategy including 
VIP > 1, |Corr(t,X)| > 0.58, and the span of CIJFjk excluding zero, 17 variables presumably 
representing individual metabolites could be considered as candidate biomarkers (Fig. 5a–c, 
Table 2). For example, N-acetyl aspartate (NAA) was labeled with a red arrow in the VIP plot, S-
plot, and loading plot with CIJFjk. NAA has the top VIP value of 5.4, which means that NAA 
contributed most for class discrimination. In the S-plot, NAA displayed the highest positive 
correlation coefficient (Corr(t,X) = 0.77) and was therefore reliable for class separation. Similar 
information was shown by CIJFjk plot where NAA had a smaller span of confidence interval. 
Thus, NAA was surely selected for further investigation of biological significance. 
 
 
Fig. 5. VIP plot (a), S-plot (b), and loading plot with CIJFjk (c) from OPLS-DA modeling of 
GC/MS spectral data deriving from all the cerebral cortex samples. 
 
Table 2.  
A list of significant compounds accountable for class discrimination 
Key Compound C H T R Metabolic function 
1 Lactate ↓
*
 – ↓
*
 – Glucose metabolism 
2 Imidazole-4-acetate ↑
*
 ↓ – ↓ Histamine metabolism 
3 Methylimidazole acetate ↑
*
 ↑ – ↓
*
 Histamine metabolism 
4 Alanine
a
 ↓
*
 ↑
*
 ↓
*
 ↑ Aspartate metabolism 
5 Glycine
a
 ↑ ↑
*
 ↑
*
 ↑  Inhibitory neurotransmitter 
6 Valine
a
 – ↑
*
 ↑
*
 ↑
*
 Glutamate synthesis 
7 Serine ↓ ↓  ↑
*
 ↑ Glycine metabolism 
8 Leucine
a
 – ↑
*
 ↑ ↑
*
 Glutamate synthesis 
9 Iso-leucine
a
 – – – ↑ Glutamate synthesis 
10 Threonine
a
 ↑ – ↑
*
 ↑ Glycine metabolism 
11 Proline
a
 – ↑
*
 – ↑
*
 Proline metabolism 
12 Asparagine
a
 ↓
*
 – – – Aspartate metabolism 
13 N-Acetyl aspartate ↑
*
 ↑
*
 ↓
*
 ↓
*
 Aspartate metabolism 
14 3-Indolepropionate – ↓
*
 – – Amino acid metabolism 
15 Aspartate
a
 ↓ ↑ ↓ – Excitatory neurotransmitter 
16 Methionine
a
 – – – ↑
*
 Cysteine metabolism 
17 Glutamate
a
 – ↑
*
 ↓ ↓
*
 Excitatory neurotransmitter 
18 Glutamine ↓
*
 ↓  – – Glutamate metabolism 
19 Phenylalanine
a
 ↑
*
 ↑
*
 ↑
*
 ↑
*
 Tyrosine metabolism 
20 Cysteine ↑
*
 – – ↓ Cysteine metabolism 
21 Hexadecanoic acid – – ↑ ↓  Fatty acid biosynthesis 
22 Lysine
a
 – ↓
*
 ↑  ↑ Amino acid metabolism 
Key Compound C H T R Metabolic function 
23 Arachidonic acid – – ↑
*
 – Lipid metabolism 
24 Tryptophan
a
 ↑
*
 – ↑
*
 – Serotonin metabolism 
The star (*) represents the |Corr(t,X)| > 0.58 and the triangle ( ) means the span of CIJFjk 
excluding zero. The short dash line (–) indicates no significant variation. The raw data are 
provided in the Supplementary Materials. Abbreviations: C, cerebral cortex; H, hippocampus; T, 
thalamus; and R, the remaining brain regions. 
 
a
 These metabolites are verified by reference compounds available. The arrow denotes the VIP 
value greater than 1.0 and the up- (or down-) regulation of the arrow represents the relative 
increased (or decreased) concentration in the CUMS-treated group as compared to the healthy 
control.  
 
3.5. Hippocampus, thalamus, and the remaining brain tissues 
GC/MS spectral datasets deriving from other three discrete brain regions were processed in a 
similar manner. Each 3D-PCA scores map  
 
GC/MS spectral datasets deriving from other three discrete brain regions were processed in a 
similar manner. Each 3D-PCA scores map showed clear separation tendency of metabolic 
profiles between the CUMS-treated group and the healthy control (Supporting Fig. 3a–c). Three 
additional OPLS-DA models confirmed the class separation for each brain region according to 
the pathophysiological status and the cross-validated OPLS-DA scores map indicated the 
stability and reliability of each OPLS-DA model (Supporting Fig. 3d–f). 
 
3.6. Summary of significant metabolites from four discrete brain tissues 
Based on MCA for OPLS-DA of four discrete brain regions, a total of 43 significant variables 
were finally obtained. Among those significant variables, 24 metabolites were readily identified 
by comparing the ion fragments with those from our GC/MS spectral databases (Table 2), and 14 
amino acids were verified using reference compounds available. Furthermore, in order to verify 
the CUMS-related metabolic variation in discrete brain regions, quantitative analysis was carried 
out on these 14 amino acids. The accurate percentage of these metabolites was calculated (Table 
3). 
 
Table 3.  
Relative percentage of variation for 14 amino acids using quantitative analysis 
Key Compound C H T R 
4 Alanine ↓23%  ↓18%
a
 – – 
5 Glycine – – ↑13% ↑24% 
6 Valine – – ↑18% ↑70%  
8 Leucine ↓18% ↑13%  ↑13% ↑57%  
Key Compound C H T R 
9 Iso-leucine – – ↑29%  ↑67%  
10 Threonine ↓14%
a
 – ↑38% ↑22%  
11 Proline ↓13% – – ↑19% 
12 Asaparagine ↓44%  – – ↑34% 
15 Aspartate ↓13%  – – – 
16 Methionine – ↑18% – ↑23% 
17 Glutamate – – – ↑16%
a
 
19 Phenylalanine – – ↑20% ↑37%  
22 Lysine ↓22% ↓24% ↑23% ↑37% 
24 Tyrptophan – ↓15% ↑33%  – 
a
 Inconsistency with multivariate statistics. 
 Statistical significance (P < 0.05, unpaired student’s t-test).  
 
4. Discussion 
With the aim of monitoring the local metabolic changes in complex neural disorder–chronic 
unpredictable mild stress, we used a GC/MS technique to profile the metabolites present in four 
discrete brain regions, including cerebral cortex, hippocampus, thalamus, and the remaining 
regions in the rats exposed repeatedly to nine different stressors for four weeks in a random 
order. Cerebral cortex is the largest part of the brain related with sophisticated brain functions 
such as thought and action; thalamus and hippocampus are important parts in the limbic system, 
which is associated with emotional reactions and has been an interest in clinical depression 
research. Thus, we focused on those four distinct brain regions for their specific biological 
functions. To our great interest, not all the metabolic variations occur consistently in the four 
brain regions in this study. For instance, lactate, as one major end product of both aerobic and 
anaerobic glycolysis [41], was found significantly decreased only in cerebral cortex and 
thalamus with sensory and motor functions. Such abnormal alteration might indicate that energy 
metabolism in cortex and thalamus was an outcome of long-time fatigue of CUMS-treated rats in 
our study. In terms of biological functions in other brain regions, a more systematic study 
involving molecular biology is needed to investigate the biochemical variations of each brain 
region in the future work. 
 
4.1. Identification of significant metabolites 
Relying on the four subsets of significant metabolites, many metabolites significantly altered 
between the CUMS-treated group and the healthy control in a certain brain region but did not 
feature across all the brain regions whereas some differential metabolites did not display 
consistent changing trend across different brain regions. Despite of such inconsistence, the 
disturbed metabolic pathways, particularly disorder of amino acid metabolism, could be 
prominently reflected in the brain [42] (Fig. 6). 
 
 
Fig. 6. The perturbed metabolic pathways especially amino acid metabolism in the stress-rats. 
Compound detected in this study was shown in bond italic font. 
 
4.2. Quantitative analysis 
According to the MCA measure, a number of 14 amino acids was identified and quantified, 
which is considered as the most significant and reliable metabolites closely associated with 
CUMS. Quantitative analysis not only provides accurately subtle metabolic variation in the brain 
tissues but also can assess the findings from multivariate statistics. Taking into consideration that 
various factors, e.g., systemic errors in weighing, extraction, and derivatization of tissue samples 
possibly interfered with the stress-related metabolic variation, we set a minimum percentage 
(13%) with statistical significance (P < 0.05) as a critical threshold (Table 3). It is reasonable that 
the concentration changes for the majority of these amino acids are fairly consistent with the 
results from multivariate statistics, except for inconsistent alteration of three compounds 
(threonine in cerebral cortex; alanine in hippocampus; glutamate in the remaining regions). Such 
inconsistency is partially due to the fact that signals of impurities and confounding noise might 
distort the data set during normalization and scaling procedures necessary for multivariate 
statistics [43] and [44]. Therefore, the present work suggested that: (1) MCA for multivariate 
statistics could be an efficient and robust approach for the selection of candidate biomarker 
metabolites; (2) quantitative analysis of significant metabolites should be accompanied to verify 
the accuracy of multivariate statistics. 
 
4.3. Amino acid metabolism 
The most significant alterations attributed to the disorder of amino acid metabolism. These 
differential amino acids can be categorized into two classes: excitatory/inhibitory 
neurotransmitters and branched-chain amino acids (BCAAs). While the intensity of glycine was 
significantly increased across the four brain regions, the variation of aspartate in each brain 
region appeared to be inconsistent towards the stressors. Interestingly, the ratio of glycine to 
aspartate (an important inhibitory/excitatory pair) was increased across all the brain regions 
especially, significantly in cortex, thalamus and the remaining brain regions (P < 0.05), which 
may suggest the importance of the intricate balance between inhibitory and excitatory amino 
acids to maintain normal brain function [24] and [45]. In addition, serving as an important 
excitatory neurotransmitter in the mammalian CNS, glutamate was decreased in thalamus and 
the remaining brain regions but increased in hippocampus. This finding suggested that glutamate 
could participate actively in the synthesis of glucose and ketone bodies for the brain in response 
to xenobiotic stimuli while the excessive release of glutamate could be associated with the brain 
impairment [46]. In parallel, the significant reduction of glutamine that can release amine and 
produce glutamate to maintain nitrogen balance was observed in cerebral cortex and 
hippocampus. Taken together, these results may be indicative of stress-induced deficiency in 
glutamate–glutamine neurotransmitter cycling. 
 
In this study, BCAAs including leucine, isoleucine, and valine, were increased in each brain 
region of the CUMS-induced rats as compared to that of the healthy controls. These BCAAs can 
transport quickly across the blood-brain barrier as major amino group donors for the synthesis of 
brain glutamate. Recent studies have demonstrated that BCAAs, especially leucine, contribute 
most to the derivation in astrocytes of glutamate and glutamine so as to maintain the homeostasis 
of brain nitrogen [47]. Additionally, the increased concentration of tryptophan was observed in 
cerebral cortex and thalamus from the stressed rat brain. The neurotransmitter 5-hydroxy-
tryptamine (5-HT) is sensitive to the fraction of tryptophan available in plasma for transport into 
the brain, as well as the concentration of BCAAs that are transported via the same carrier system. 
Thus, the increased concentration of both tryptophan and BCAAs could indicate the disturbed 
release of brain 5-HT that is highly related with the central fatigue [48]. Hence, the increased 
BCAAs and tryptophan may suggest the impaired glutamate homeostasis in the brain as well as 
reflect central fatigue in response to the chronic stress. 
 
4.4. NAA metabolism 
The significant perturbation of NAA was also responsible for discriminating metabolic profiles 
between the CUMS-treated rats and the healthy controls, showing an increase in cerebral cortex 
and hippocampus while a decrease in thalamus and the remaining brain regions. NAA is 
synthesized in the mitochondria and considered as a marker for neuronal density [24] and [49]. 
Generally, decrease in the concentration of NAA occurs in conditions of neuronal damage or 
loss, such as chronic psychosocial stress and perinatal stress [50] and [51]. Meanwhile, the 
increase of NAA in two brain regions may reflect the stress-induced complementary increase of 
amino acids for its metabolic function of transferring amino nitrogen from the mitochondrion to 
the cytoplasm [52]. It is clear that each subtle yet significant variation of metabolites has its own 
biochemical function in response to or resulting in chronic mild stress (Table 3). 
 
In summary, the combined use of GC/MS analytical technique and multivariate statistics 
facilitate the discrimination of metabolic profiles in different brain tissues including cortex, 
hippocampus, thalamus, and the remaining brain regions between the CUMS-treated rats and the 
healthy controls. The disorder of amino acid metabolism is significant across all the brain tissues, 
partially suggesting the impairment of neural activity of CNS. In addition, the utility of MCA in 
variable selection greatly improves reliability of the differential metabolites. Using this tissue-
targeted metabolic profiling strategy, we are able to recognize an integrated, perturbed biological 
pathway-disorders of amino acid metabolism associated closely with the stress-related 
pathological variation in the brain. 
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S1. SUPPORTING METHODS AND RESULTS 12 
This section involves animal handling and sampling , sucrose preference test, 13 
open-filed test, sample preparation, GC/MS assay, data acquisition and pretreatment, and 14 
quantitative analysis.  15 
S1-1 Animal handling and sampling 16 
  The study was approved by national legislations of China and local guidelines. A total 17 
of twelve eight-week-old male Sprague-Dawley (S.D.) rats (weighing 200 ± 20 g) was 18 
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commercially obtained from Shanghai Laboratory Animal Co. Ltd. (SLAC, Shanghai, 1 
China), and kept at a barrier system with regulated environment (24 ± 1 °C, 45 ± 15 % 2 
relative humidity, and 12h/12h light/dark cycle). The rats were fed with a certified 3 
standard rat chow and tap water ad libitum. After two-week acclimation, all of the rats 4 
were randomly divided into two groups (n = 6 per group): the healthy control group 5 
versus the CUMS-treated group in which the rats were repeatedly exposed to a set of 6 
chronic unpredictable mild stressors. The CUMS procedures includes nine different kinds 7 
of stressors as follows: 5 min of forced swimming in 15 °C water; exposure to an 8 
experimental room at 40 °C and -10 °C for 5 min, respectively; 24 hour of food 9 
deprivation and 24 hour of water deprivation, respectively; 6 unpredictable shocks: 15 V, 10 
20 sec duration, one shock/10 sec; tail clamp for 1 min; inversion of light/dark cycle; 2 11 
hour of restricted movement (confinement in a mouse cage). One stressor was applied per 12 
day and the whole stress procedure lasted for four weeks with a completely random order. 13 
The healthy control rats were housed undisturbed in another experiment room under the 14 
same condition. They had free access to tap water and food except for the period of water 15 
and food deprivation prior to the sucrose preference test. At the 4
th
 week of the entire 16 
experiment, all of the rats were sacrificed with sodium pentobarbital anesthesia (40 17 
mg/100 g body weight, i.p.). Brain tissues including cerebral cortex, hippocampus, 18 
thalamus, and remaining brain regions were obtained from each rat carefully and 19 
instantly stored at -80 °C before assay.  20 
S1-2 Sucrose preference test 21 
  The depressive-like behavioral state was assessed by a sucrose preference test as 22 
described. After a 20-hour period of water and food deprivation, each rat was subjected to 23 
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an individual metabolic cage in which two bottles containing water and 1% sucrose 1 
solution were placed. The ratio of the amount of sucrose solution to that of total solution 2 
ingested within one hour represented the parameter of hedonic behavior. Sucrose 3 
preference test was trained for three times before the commencement of the stress 4 
procedure. 5 
S1-3 Open-field test 6 
 Open-field test was conducted in a quiet room between 13:00 and 15:00 p.m. at a 7 
rectangular arena 80×80 cm with 40-cm-high side walls, the floor marked with a grid 8 
dividing it into 25 equal-size squares. Each animal was placed in the central square at 9 
first and observed for 5 min. Scores were calculated by the amount of time that rats spent 10 
grooming and rearing (defined as standing upright on its hind legs, one score for once) 11 
and by the number of grid lines rats can cross using at least three paws (every grid 12 
crossed counts one score). In this study, reduced activity and curiosity of CUMS-induced 13 
rats was indicated by low horizontal and vertical scores (40±13 for CUMS-treated rats 14 
versus 72±24 for the healthy controls, p <0.05), the depressive state was in accordance 15 
with the clinical psychomotor hysteresis symptoms of depression very well. 16 
S1-4 Sample preparation 17 
  The extraction and two-step derivatization procedures were conducted as our 18 
previously described with minor modification. In brief, each 80-mg aliquot of brain tissue 19 
samples was homogenized (T10 basic ULTRA-TURRAX homogenizer, IKA® Group, 20 
Staufen, Germany) with 400 µL of ultrapure water (Milli-Q system, Millipore, USA) for 21 
1 min in an ice bath, with the pH of the system being adjusted to 10.0 using about 10~20 22 
µL of 7 mol/L NaOH. The resultant mixtures were centrifuged at 8, 000 g for 10 min at 23 
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4 °C to remove precipitates and debris. After a 400-μL aliquot of the supernatant was 1 
transferred to a screw-top glass tube, additional 200 μL of water, 400 μL of anhydrous 2 
ethanol, 100 µL of L-2-chlorophenylalanine (internal standard, Shanghai Intechem Tech. 3 
Co. Ltd., China), 100 µL of pyridine, and 50 µL of ethyl chloroformate (ECF, China 4 
National Pharmaceutical Group Corporation, Shanghai, China) were supplied for 5 
derivatization. The resultant ECF-derivatives was isolated and dried with anhydrous 6 
sodium sulfate for following GC/MS analysis. 7 
  Note: The purpose of the selected following paragraph from our accepted paper is to 8 
explain why we used a GC/MS method with ECF derivatization for studying 9 
neurochemical changes in the stress-related rat brain. (With the permission of all the 10 
coauthors in that paper) 11 
  The brain is a highly complex system embracing a vast array of mutually interacting 12 
endogenous, small-molecule metabolites with varied chemical properties and specific 13 
biological significance. These metabolites in brain tissue, typically, amino acids and fatty 14 
acids are intermediates in cellular metabolism and play an indispensable role in 15 
regulating neural activity of central nervous system. The variation of them are of high 16 
significance for understanding the underlying mechanisms of various neurological 17 
diseases. Therefore, great effort has been made to qualify and quantify these crucial 18 
compounds in the brain tissues. 19 
  GC-MS technique serves as a versatile analytical tool and allows simultaneous 20 
detection of different classes of metabolites in a single analysis. Such a technique exhibits 21 
satisfactory sensitivity and selectivity than conventional NMR approach, and a good 22 
reliability in structure identification of candidate biomarkers than LC-MS. Moreover, 23 
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ethyl chloroformate (ECF) derivatization, as a simple and robust procedure, has proven 1 
preferable in the determination of amino acids. This derivatization has been of 2 
considerable interest, as ECF is an inexpensive agent and the reaction can be performed 3 
directly in aqueous medium without requirement for sample heating, which greatly 4 
facilitates batch preparation and improves reproducibility in quantifying amino acids. 5 
S1-5 GC/MS spectral acquisition 6 
  Each 1-µL of the analyte was injected into a HP-5ms capillary column (30 m × 250 µm 7 
i.d., 0.25-µm film thickness; 5%-phenyl-methylpolysiloxane bonded and crosslinked; 8 
Agilent J&W Scientific, Folsom, CA, USA) and analyzed by a hyphenated analytical 9 
technique, an Agilent 6890N gas chromatography coupled with an Agilent 5975B inert 10 
MSD mass spectrometry (Agilent Tech., CA, USA). 11 
S1-6 Data pretreatment 12 
  All of the raw GC/MS spectral data files were converted to NetCDF format via data 13 
analysis interface of the Agilent Instrument (Agilent Tech., CA, USA). Each data file was 14 
extracted using our custom scripts in the MATLAB R2007a (The MathWorks, Inc., 15 
Natick, MA, USA), where data pretreatment procedures such as baseline correction, peak 16 
deconvolution and alignment, exclusion of internal standard and solvent peaks, and 17 
normalization to the total chromatogram were constructed afterwards. The output data 18 
were organized in a three-dimensional matrix encompassing arbitrarily annotated peak 19 
indices (RT-M/Z pairs), sample names (observations), and all of the peak areas 20 
(variables). 21 
S1-7 Correlation coefficients 22 
  Correlation coefficients were calculated by using Pearson linear correlation 23 
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coefficients incorporated in MATLAB R2007a (The MathWorks, Inc., Natick, MA, USA). 1 
Firstly, all the GC/MS data were set as X matrix, and OPLS-DA discriminant scores in 2 
the first predictive component as Y matrix. Then, we repeatedly calculated the correlation 3 
coefficients of each variable and discriminant scores using Matlab function [R, 4 
p]=corrcoef (X, Y). [R,P]=corrcoef(...) also returns P, a matrix of p-values for testing the 5 
hypothesis of no correlation. Each p-value is the probability of getting a correlation as 6 
large as the observed value by random chance, when the true correlation is zero. If P(i,j) 7 
is small, say less than 0.05, then the correlation R(i,j) is significant.  8 
S1-8 Analytical assay and quantitative analysis 9 
  In this study, we firstly established a reliable and efficient method for global analysis 10 
of water extracts from brain tissue samples. This method has been detailedly described 11 
elsewhere (unpublished paper). Briefly, the protocol was extensively evaluated using 12 
brain tissue samples and a set of 23 reference standards encompassing amino acids, 13 
amines, and organic acids. Acceptable calibration curves were obtained over a wide 14 
concentration range, 0.2-35.0 μg/mL for standards and 0.067-0.417 mg/μL (w/v, 15 
tissue/water) for brain tissue samples.  The precision of the samples analyzed was 16 
mostly lower than 10% for both the mixed standard solution and the brain tissue samples.  17 
The brain tissue samples exhibited good stability within 48 hours with RSD generally 18 
less than 15%.   19 
Quantitative analysis of the 14 amino acids was herein carried out using the analytical 20 
curves that were constructed using solutions at a concentration of 0.2, 0.5, 1.0, 5.0, 10.0, 21 
15.0, 20.0, 25.0, or 35.0 μg/ml. The selected ion that exhibits the strongest response 22 
without disturbance was used to calculate the content for each amino acid in each brain 23 
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region. The expression can be described as  1 
X sample, i = X standard, i × (Y sample, i / Y standard, i – B adj, i) / K adj, i 2 
X sample, i : Concentration of the i
th
 amino acid in the test sample, μg/ml; 3 
X standard, i : Concentration of the i
th
 amino acid standard, μg/ml; 4 
Y sample, i : Area of the test sample (adjusted by the internal standard); 5 
Y standard, i : Area of the i
th
 amino acid (adjusted by the internal standard); 6 
B adj, i Interception of the established calibration curve using the i
th
 amine acid 7 
standard; 8 
K adj, i Slope of the established calibration curve using the i
th
 amine acid standard. 9 
 i, Alanine, Glycine, Valine, Leucine, Isoleucine, Threonine, Proline, Aspartic acid, 10 
Methionine, Glutamic acid, Phenylalanine, Tryptophan, Lysine, and Aspatagine 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
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 1 
Linearity of  quantification of amino acid standards 
Compound Linear range (µg/ml)
  a
 n corr. coeffs.
b
 
Alanine 0.2-35.0 9 0.9992 
Glycine 0.2-35.0 9 0.9995 
Valine 0.2-35.0 9 0.9992 
Leucine 0.2-35.0 9 0.9996 
Isoleucine 0.2-35.0 9 0.9993 
Threonine 0.2-20.0 8 0.9983 
Proline 0.2-35.0 9 0.9985 
Aspartic acid 0.2-35.0 9 0.9908 
Methionine 0.5-25.0 7 0.9989 
Glutamic acid 0.2-25.0 7 0.9981 
Phenylalanine 0.5-25.0 7 0.9981 
Tryptophan 5.0-35.0 6 0.9907 
Lysine 5.0-35.0 6 0.9979 
Aspatagine 5.0-35.0 6 0.9990 
a
 Each standard stock solution of test compounds was freshly prepared in distilled water 
(0.8 mg/ml). The mixed standard solution was obtained by adding 100 µl of each stock 
solution described above. Different volumes of the mixed standard solution were diluted 
into 600 µl of water for linear range determination. 
 b
 Correlation coefficients were 
calculated for linearity ranging at the concentration listed here.  
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S2. SUPPORTING FIGURES 1 
SUPPORTING FIG. 1. Typical GC/MS total ion current (TIC) chromatograms of each region of brain tissue samples from the 2 
CUMS-treated rats ((a) cerebral cortex, (b) hippocampus, (c) thalamus, and (d) the remaining brain regions) and the healthy rats ((e) 3 
cerebral cortex, (f) hippocampus, (g) thalamus, and (h) the remaining brain regions). 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
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SUPPORTING FIG. 2. 2D-PCA scores map (PC1 versus PC2) and 3D-PCA scores map (PC1 versus PC2 versus PC3) of GC/MS 1 
data deriving from the four discrete brain regions of the CUMS-treated group and the healthy control group (n = 6 per group).  2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
Note: In this study, a five-component PCA model with R2X of 67% was obtained. We only provided the 2D PCA scores plot 
(PC1 versus PC3) in the TEXT to indicate the inherent differences between brain regions and in relation to stress factors. 
From this map, we can notice the differences between cerebral cortex or thalamus versus hippocampus or the remaining 
regions occurred mainly in the PC1 while the consequences of stress are clearly shown in the PC3. The remaining principal 
components could represent other metabolic differences e.g., PC2 displayed the metabolic differences between thalamus or 
the remaining regions versus hippocampus (2b), inter-individual differences, and analytical variations etc., therefore, we 
provided the two additional figures for better understanding of our work. 
a 
b 
12 
 
SUPPORTING FIG. 3. 3D-PCA scores map of GC/MS data deriving from (a) 1 
hippocampus, (b) thalamus, and (c) the remaining brain regions obtained from the 2 
CUMS-treated group versus the healthy control group (n = 6 per group). 1D 3 
cross-validated OPLS-DA score map of GC/MS data deriving from (d) hippocampus, 4 
(e) thalamus, and (f) the remaining brain regions obtained from the CUMS-treated 5 
group versus the healthy control group (n = 6 per group). The modeled score value 6 
(t[1]p), the 6
th
 round cross-validated score value (t[1]cv,6), and orthogonal score value 7 
(t[2]o) for each individual are illustrated for each observation.  8 
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